Jpmorgan Chase & Co »

Amneal Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 186k 6.07
2023-09-30 $2.5M 587k 4.22
2023-06-30 $1.7M 533k 3.10
2023-03-31 $629k 236k 2.66
2022-12-31 $611k 307k 1.99
2022-06-30 $1.2M 374k 3.18
2022-03-31 $1.5M 363k 4.17
2021-12-31 $1.7M 363k 4.79
2021-03-31 $3.0M 424k 7.14
2020-12-31 $2.2M 488k 4.58
2020-09-30 $142k 37k 3.84
2020-06-30 $150k 34k 4.46
2020-03-31 $212k 39k 5.43
2019-12-31 $201k 42k 4.75
2019-09-30 $968k 334k 2.90
2019-06-30 $354k 50k 7.07
2019-03-31 $334k 24k 14.04
2018-12-31 $337k 25k 13.69
2018-09-30 $537k 24k 22.25
2018-06-30 $352k 21k 16.43